Is Edwards Lifesciences Corporation overvalued?

Edwards Lifesciences Corporation (EW) looks overvalued — trading about 35% above its fair value.

Overvalued

Price

$90.78

Fair value

$59.05

Current P/E

49.6

Normal P/E

32.3

Market cap

$52.27B

Dividend yield

0.0%

Return on equity

10.4%

Sector

Healthcare

Fair value compares EW's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 28 Jun 2026.

Related stocks